A Phase Ii Open-Label Clinical Study of Efficacy and Safety of Recombinant Human N-Acetylgalactosamine 4-Sulfatase (Rhasb) Enzyme Replacement Therapy in Patients with Mucopolysaccharidosis Vi (Maroteaux-Lamy Syndrome).
AuthID
P-000-EH7
P-000-EH7